Assignee
INTARCIA THERAPEUTICS INC
US·49 granted patents·23 pending applications·948 citations·filing 2003–2023
Top patents by PatentIndex Score
72 records- 0199US7682356B2Osmotic delivery systems and piston assemblies for use thereinINTARCIA THERAPEUTICS INC·Filed 2007·Granted Mar 23, 2010·84 cites·22 claims
- 0298US8992962B2Two-piece, internal-channel osmotic delivery system flow modulatorINTARCIA THERAPEUTICS INC·Filed 2013·Granted Mar 31, 2015·29 cites·49 claims
- 0398US8372424B2Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehiclesINTARCIA THERAPEUTICS INC·Filed 2012·Granted Feb 12, 2013·81 cites·21 claims
- 0498US8367095B2Two-piece, internal-channel osmotic delivery system flow modulatorINTARCIA THERAPEUTICS INC·Filed 2012·Granted Feb 5, 2013·33 cites·28 claims
- 0597US9526763B2Solvent/polymer solutions as suspension vehiclesINTARCIA THERAPEUTICS INC·Filed 2015·Granted Dec 27, 2016·24 cites·20 claims
- 0697US7919109B2Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehiclesINTARCIA THERAPEUTICS INC·Filed 2008·Granted Apr 5, 2011·35 cites·20 claims
- 0797US7316680B2Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channelINTARCIA THERAPEUTICS INC·Filed 2005·Granted Jan 8, 2008·35 cites·8 claims
- 0896US9682127B2Osmotic delivery device comprising an insulinotropic peptide and uses thereofINTARCIA THERAPEUTICS INC·Filed 2016·Granted Jun 20, 2017·21 cites·30 claims
- 0996US9539200B2Two-piece, internal-channel osmotic delivery system flow modulatorINTARCIA THERAPEUTICS INC·Filed 2015·Granted Jan 10, 2017·23 cites·24 claims
- 1096US9095553B2Solvent/polymer solutions as suspension vehiclesINTARCIA THERAPEUTICS INC·Filed 2012·Granted Aug 4, 2015·27 cites·17 claims
- 1196US8052996B2Two-piece, internal-channel osmotic delivery system flow modulatorINTARCIA THERAPEUTICS INC·Filed 2007·Granted Nov 8, 2011·37 cites·17 claims
- 1296US8048438B2Stable non- aqueous single phase viscous vehicles and formulations utilizing such vehiclesINTARCIA THERAPEUTICS INC·Filed 2008·Granted Nov 1, 2011·35 cites·20 claims
- 1396US7959938B2Polyoxaester suspending vehicles for use with implantable delivery systemsINTARCIA THERAPEUTICS INC·Filed 2006·Granted Jun 14, 2011·37 cites·18 claims
- 1496US7879028B2Osmotic delivery systems and piston assemblies for use thereinINTARCIA THERAPEUTICS INC·Filed 2010·Granted Feb 1, 2011·72 cites·16 claims
- 1596US7655257B2Sustained delivery of an active agent using an implantable systemINTARCIA THERAPEUTICS INC·Filed 2003·Granted Feb 2, 2010·50 cites·23 claims
- 1695US9889085B1Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1cINTARCIA THERAPEUTICS INC·Filed 2015·Granted Feb 13, 2018·18 cites·23 claims
- 1794US9572889B2Devices, formulations, and methods for delivery of multiple beneficial agentsINTARCIA THERAPEUTICS INC·Filed 2014·Granted Feb 21, 2017·23 cites·63 claims
- 1894US8343140B2Devices, formulations, and methods for delivery of multiple beneficial agentsINTARCIA THERAPEUTICS INC·Filed 2009·Granted Jan 1, 2013·30 cites·20 claims
- 1994US7964183B2Composition and dosage form comprising a particle formulation and suspending vehicleINTARCIA THERAPEUTICS INC·Filed 2009·Granted Jun 21, 2011·28 cites·22 claims
- 2093US7731947B2Composition and dosage form comprising an interferon particle formulation and suspending vehicleINTARCIA THERAPEUTICS INC·Filed 2004·Granted Jun 8, 2010·46 cites·24 claims
- 2193US7407499B2Osmotic pump with self-retaining, fast-start membrane plugINTARCIA THERAPEUTICS INC·Filed 2004·Granted Aug 5, 2008·39 cites·19 claims
- 2290US11840559B2Glucagon-receptor selective polypeptides and methods of use thereofINTARCIA THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·1 cites·19 claims
- 2389US11739134B2Long acting peptide tyrosine tyrosine (PYY) analogs and methods of useINTARCIA THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·2 cites·20 claims
- 2487US11214607B2Glucagon-receptor selective polypeptides and methods of use thereofINTARCIA THERAPEUTICS INC·Filed 2019·Granted Jan 4, 2022·3 cites·20 claims
- 2586USD840030SImplant placement guideINTARCIA THERAPEUTICS INC·Filed 2016·Granted Feb 5, 2019·25 cites·1 claims
- 2685US7655254B2Implantable device for continuous delivery of interferonINTARCIA THERAPEUTICS INC·Filed 2006·Granted Feb 2, 2010·44 cites·33 claims
- 2784US10501517B2Glucagon-receptor selective polypeptides and methods of use thereofINTARCIA THERAPEUTICS INC·Filed 2017·Granted Dec 10, 2019·4 cites·61 claims
- 2883US11654183B2Methods comprising continuous administration of exenatide and co-administration of a drugINTARCIA THERAPEUTICS INC·Filed 2020·Granted May 23, 2023·1 cites·14 claims
- 2983US7727519B2Method for treating hepatitis C virus with omega interferonINTARCIA THERAPEUTICS INC·Filed 2004·Granted Jun 1, 2010·34 cites·22 claims
- 3079US7011851B2Oxidized collagen formulations for use with non-compatible pharmaceutical agentsINTARCIA THERAPEUTICS INC·Filed 2003·Granted Mar 14, 2006·14 cites·9 claims
- 3178US10159714B2Compositions, devices and methods of use thereof for the treatment of cancersINTARCIA THERAPEUTICS INC·Filed 2017·Granted Dec 25, 2018·2 cites·8 claims
- 3275US12122816B2Long acting peptide tyrosine tyrosine (PYY) analogs and methods of useINTARCIA THERAPEUTICS INC·Filed 2023·Granted Oct 22, 2024·0 cites·25 claims
- 3375US10925639B2Implant placement and removal systemsINTARCIA THERAPEUTICS INC·Filed 2016·Granted Feb 23, 2021·2 cites·26 claims
- 3474US12042557B2Rapid establishment and/or termination of substantial steady-state drug deliveryINTARCIA THERAPEUTICS INC·Filed 2020·Granted Jul 23, 2024·0 cites·24 claims
- 3569US2017319662A1Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehiclesINTARCIA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3669US2008269726A1Osmotic pump with self-retaining, fast-start membrane plugINTARCIA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3769US2009087408A1Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable deviceINTARCIA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3868US2017119855A1Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehiclesINTARCIA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3966US12084485B2Long acting glucagon like polypeptide-1 (GLP-1) receptor agonists and methods of useINTARCIA THERAPEUTICS INC·Filed 2021·Granted Sep 10, 2024·0 cites·28 claims
- 4066US12018059B2Human amylin analog polypeptides and methods of useINTARCIA THERAPEUTICS INC·Filed 2019·Granted Jun 25, 2024·0 cites·35 claims
- 4166US10583080B2Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1cINTARCIA THERAPEUTICS INC·Filed 2018·Granted Mar 10, 2020·0 cites·27 claims
- 4266US2020360267A1THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1cINTARCIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4366US2017181964A1Two-piece, internal-channel osmotic delivery system flow modulatorINTARCIA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4466US2017348392A1Solvent/polymer solutions as suspension vehiclesINTARCIA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4566US2015057227A1Compositions, devices and methods of use thereof for the treatment of cancersINTARCIA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4665US10441528B2Devices, formulations, and methods for delivery of multiple beneficial agentsINTARCIA THERAPEUTICS INC·Filed 2018·Granted Oct 15, 2019·0 cites·21 claims
- 4765US2008112994A1Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic mediumINTARCIA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 4865US2017056476A1Solvent/polymer solutions as suspension vehiclesINTARCIA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4964US2020397690A1THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1cINTARCIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5063US10869830B2Rapid establishment and/or termination of substantial steady-state drug deliveryINTARCIA THERAPEUTICS INC·Filed 2018·Granted Dec 22, 2020·0 cites·21 claims
Showing the top 50 of 72 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when INTARCIA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →